Expression of ST2, a possible diagnostic marker of HSCT-TMA as previously discussed, before HSCT was also found to be a prognostic marker for one-year nonrelapse mortality and severe GVHD [112]. The gene discussed is IL1RL1; the disease is graft versus host disease.